ImmuCell Stock Price Patterns
| ICCC Stock | USD 6.07 -0.08 -1.30% |
Momentum
Impartial
Oversold | Overbought |
The hype mapping for ImmuCell connects headline volume with price response patterns. Headline volume and price changes are compiled from publicly available sources. The dataset includes peer-based comparisons of attention and response.
Hype and Price Pattern for ImmuCell
Headline and social attention around ImmuCell provide a sentiment layer for price context. The view presents sentiment data as context for near-term price behavior analysis. Price and volume history from exchange records underpins the dataset.
Sentiment-price alignment for ImmuCell is organized for structured contextual review. The data is shown as reference context rather than a directional signal. All metrics are computed from historical trading data across available periods. No forward-looking guarantees are expressed or implied by this data.
This sentiment view summarizes headline intensity and market attention around ImmuCell. Hype analysis for ImmuCell highlights attention shifts in public markets. Public commentary and news volume are organized to frame price behavior context.
ImmuCell after-hype prediction price | $ 6.07 |
This analysis adds an attention layer to forecasting, technical studies, and analyst estimates. Momentum and earnings context provide additional reference points for interpretation. Combining attention data with other signals supports more structured interpretation.
ImmuCell | Build portfolio with ImmuCell Stock |
The concept of mean reversion suggests that ImmuCell's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
After-Hype Price Density Analysis
The price distribution graph for ImmuCell visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of ImmuCell's outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for ImmuCell after major news events are estimated from historical precedent. ImmuCell's after-hype downside and upside margins for the prediction period are 3.27 and 8.87, respectively. This approach captures the empirical distribution of ImmuCell's short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to ImmuCell assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. ImmuCell is Slightly Elevated at this time.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ImmuCell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ImmuCell backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ImmuCell, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 2.80 | 0.43 | 0.02 | 21 Events | 8 Events | In 21 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.07 | 6.07 | 0.00 |
|
Hype Timeline
ImmuCell is currently traded for 6.07. The company has historical hype elasticity of -0.43, and average elasticity to hype of competition of 0.02. ImmuCell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 58.33%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.09%. %. The volatility of related hype on ImmuCell is about 1327.01%, with the expected price after the next announcement by competition of 6.09. About 28.0% of the company shares are held by company insiders. The book value of ImmuCell was currently reported as 3.3. The company has Price/Earnings (P/E) ratio of 195.0. ImmuCell had not issued any dividends in recent years. The company completed a 1:100 stock split on 25th of July 1990. Given the investment horizon of 90 days the next forecasted press release will be in 21 days. ImmuCell Basic Forecasting Models add a structured statistical layer to the projection analysis for ImmuCell. Quantitative models complement qualitative projection inputs for ImmuCell.Related Hype Analysis
The relationship between ImmuCell and its sector peers means that news affecting one company often reverberates across ImmuCell's competitive landscape. Tracking peer hype provides context foranticipate ImmuCell's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EQ | Equillium | -0.05 | 8 per month | 5.11 | 0.17 | 14.12 | -7.83 | 39.57 | |
| CUE | Cue Biopharma | 1.49 | 8 per month | 0.00 | -0.04 | 10.71 | -12.90 | 50.98 | |
| OTLK | OUTLOOK THERAPEUTICS INC | -0.05 | 9 per month | 0.00 | -0.21 | 11.36 | -14.29 | 72.05 | |
| COEP | Coeptis Therapeutics | -0.46 | 4 per month | 0.00 | -0.06 | 7.44 | -4.52 | 28.94 | |
| OSTX | OS Therapies Incorporated | 0.04 | 30 per month | 0.00 | 0.01 | 6.94 | -5.41 | 14.56 | |
| NRXP | NRX Pharmaceuticals | 0.03 | 9 per month | 4.46 | 0.02 | 8.57 | -7.26 | 19.94 | |
| FBIO | Fortress Biotech | 0.06 | 6 per month | 0.00 | 0.01 | 6.90 | -7.14 | 26.01 | |
| IPSC | Century Therapeutics | 0.05 | 11 per month | 5.25 | 0.28 | 14.84 | -9.09 | 59.27 | |
| SNTI | Senti Biosciences | 0.97 | 17 per month | 0.00 | -0.06 | 6.90 | -7.22 | 20.63 | |
| GNTA | Genenta Science SpA | 0.03 | 4 per month | 0.00 | -0.16 | 8.70 | -13.33 | 33.85 |
ImmuCell Additional Predictive Modules
Forecasting ImmuCell's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Backtested accuracy does not guarantee forward performance - market structure and volatility regimes evolve.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Average Directional Movement Index | ||
| Average Directional Movement Index Rating | ||
| Absolute Price Oscillator | ||
| Absolute Price Oscillator | ||
| Aroon | ||
| Aroon | ||
| Aroon Oscillator | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Balance Of Power |
Sentiment Indicators & Methodology
Sentiment analysis for ImmuCell evaluates news tone, positioning, and narrative momentum. Headline intensity can influence short-horizon pricing dispersion. ImmuCell has a market cap of 54.73 M, P/E of 195.0, ROE of 6.61%.
For ImmuCell, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| DVLT | Datavault AI | |
| SEDG | SolarEdge Technologies | |
| CSIQ | Canadian Solar |
Popular Tools for ImmuCell Stock analysis
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |